INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
RM

Radhakrishnan Maha

DirectorCIK 0002013423

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score9
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
RM
Radhakrishnan MahaDirector
CADLCandel Therapeutics, Inc.
Grant or award
A—
32.0K sh
Jun 23, 2026Jun 24, 2026
traded Jun 23, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Candel Therapeutics, Inc.Director · Jun 24, 2026
  • Insider ofevidence
    Entrada Therapeutics, Inc.Director · Jun 12, 2026
9
RM
Radhakrishnan MahaDirector
TRDAEntrada Therapeutics, Inc.
Grant or award
A
—
19.0K sh
Jun 10, 2026
Jun 12, 2026
traded Jun 10, 2026
+2d
SEC FORM 4

Evidence